Tirzepatide with B12: Lilly's Impurity Warning, Risks
Tirzepatide and b12: what compounded versions are, their FDA status, and the risks.
- Active ingredient
- tirzepatide
- FDA status
- Compounded copies are not FDA approved
A quick look at Zepbound
Its half-life spans 5 to 6 days. By 5.5 d half is gone, and about 3% is left once five half-lives have passed, which comes to 27.5 d.
In SURMOUNT-1 after 72 weeks, the result was 20.9% of body weight, compared with 3.1% on placebo.
In US dollars, monthly price points cover list price and self-pay offers. Every figure was read from the price page published by the maker.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.